Subscribe To
L3harris secures $947m contract to improve b-52 self-defense
L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...
October 5, 2021, 11:52 am
L3harris secures $947m contract to improve b-52 self-defense
L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...
October 5, 2021, 11:52 am
L3harris secures $947m contract to improve b-52 self-defense
L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...
October 5, 2021, 11:52 am
L3harris secures $947m contract to improve b-52 self-defense
L3Harris Technologies Inc (NYSE: LHX) received a new 10-year, sole-source $947 million IDIQ contract to modernize the U.S. Air Force B-52 aircraft ...
October 5, 2021, 11:52 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination to protect people with a poor immune response ...
October 5, 2021, 4:31 am